Get the Stockscreener App
0.1557
5.20%
0.0077
After Hours:
.14
-0.0157
-10.08%
Virax Biolabs Group Ltd stock is traded at $0.1557, with a volume of 7.68M.
It is up +5.20% in the last 24 hours and down -18.48% over the past month.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
See More
Previous Close:
$0.148
Open:
$0.138
24h Volume:
7.68M
Relative Volume:
0.68
Market Cap:
$1.16M
Revenue:
$3,000
Net Income/Loss:
$-5.65M
P/E Ratio:
-0.1244
EPS:
-1.2521
Net Cash Flow:
$-5.88M
1W Performance:
+3.80%
1M Performance:
-18.48%
6M Performance:
-75.68%
1Y Performance:
-85.31%
1-Day Range:
$0.138
$0.16
1-Week Range:
$0.10
$0.1954
52-Week Range:
$0.10
$1.20
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.1557 | 1.10M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
Virax Biolabs (VRAX) Outlines Strategic Vision and Key Milestones - GuruFocus
Virax Biolabs CEO Sets Near-Term Milestones as ViraxImmune Strategy Advances and Valuation Lags - TipRanks
Virax Biolabs (NASDAQ: VRAX) maps ViraxImmune PAIS plan and notes cash-rich valuation gap - Stock Titan
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Nasdaq most active stocks: - MSN
Virax Biolabs : Investor Presentation (Virax Biolabs Investor Deck Q2 2026) - marketscreener.com
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - PR Newswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Which stocks are moving on Monday? - ChartMill
These stocks are making the most noise in today's session. - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Weekly Recap: Is Virax Biolabs Group Limited stock forming a cup and handleEarnings Beat & Reliable Intraday Trade Plans - baoquankhu1.vn
Dow Dips Over 350 Points; Goldman Sachs Posts Upbeat Earnings - Benzinga
Which stocks are moving before the opening bell on Monday? - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Trending Stocks Today | Virax Biolabs Soars 88.08% Pre-Market - Moomoo
VRAX.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VRAX.O Technical Analysis & Stock Price Forecast - Intellectia AI
VRAX.O PE Ratio & Valuation, Is VRAX.O Overvalued - Intellectia AI
Aug Weekly: Will Virax Biolabs Group Limited outperform the market in YEAREarnings Recap Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Trending Stocks Today | Virax Biolabs Surges 62.43% Post-Market - Moomoo
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Virax Biolabs Announces Full Exercise of Pre-Funded Warrants From $5 Million Private Placement - TipRanks
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
Warrant exercises lift Virax Biolabs (VRAX) to 19.9M shares outstanding - Stock Titan
Aug Catalysts: Whats next for Virax Biolabs Group Limited stock2026 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
9 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
VIRAX BIOLABS GROUP PB Ratio: 0.17 — 71% Below Median - GuruFocus
VRAX Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Which stocks have an unusual volume on Wednesday? - ChartMill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virax Biolabs subsidiary receives ISO quality certifications By Investing.com - za.investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Top movers in Tuesday's after hours session - ChartMill
Director Nelson Haight reports Virax Biolabs (VRAX) stock option awards - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Which stocks are experiencing notable movement on Tuesday? - ChartMill
What's Behind The Jump In Virax Biolabs Stock? - Benzinga
The market is filled with gapping stocks in Tuesday's session. - ChartMill
Discover the top movers in Tuesday's pre-market session. - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Virax adds medical-device quality standards as U.S. studies advance - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
If You Invested $1,000 in CDT Equity (CDT) - Stock Titan
If You Invested $1,000 in Virax Biolabs Group Ltd (VRAX) - Stock Titan
If You Invested $1,000 in Scinai Immunotherapeutics Ltd. (SCNI) - Stock Titan
Fundamentals Check: Does CIGC offer margin of safetyGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Virax Biolabs (NASDAQ: VRAX) COO discloses multiple long-dated stock options - Stock Titan
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):